对治疗疼痛和的 κOR 偏向激动剂的局限性和潜力
Amal El Daibani1, Manish K Madasu1, Ream Al-Hasani1
1Center for Clinical Pharmacology, Department of Anesthesiology, Washington University School of Medicine, Saint Louis, MO, USA.
Neuropharmacology
|July 3, 2024
概括
开发卡帕-阿片类受体 (κOR) 的偏向配体旨在最大限度地提高治疗效果,如缓解疼痛,同时最大限度地减少副作用. 研究正在探索G蛋白对比β-arrestin的信号传递,以实现这一目标.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- 连接物偏差允许不同的受体反应,影响治疗与不良影响.
- 卡帕阿片类受体 (κOR) 连接体的发展越来越多地集中在偏差上,偏好G蛋白而不是β-arrestin信号来缓解疼痛和.
- β-arrestin 2 在 κOR 副作用中的作用以及 G 蛋白偏差 κOR 激动剂的特征仍然不清楚.
研究的目的:
- 审查测试在 κOR 的联结偏差的方法.
- 讨论 κOR 激动剂偏差因子测量的局限性.
- 推系统因素来关联信号偏差与药理效应.
主要方法:
- 对评估带偏差的既定方法的审查.
- 对 κOR 激动剂当前偏差因子测量技术的局限性分析.
- 对偏差与药物效应相关性考虑额外的系统因素.
主要成果:
- 目前用于测量 κOR 的联结偏差的方法有局限性.
- 一些所谓的G蛋白偏差配体可能是部分或低效的激动剂.
- β-arrestin 2 对 κOR 中介副作用的确切贡献尚未完全理解.
结论:
- 准确评估带偏差对于 κOR 向药物开发至关重要.
- 需要进一步的研究来确定偏向 κOR 激动剂的治疗和副作用概况.
- 建议整合超出简单偏差测量的系统因素,以便更好地预测药理结果.
相关概念视频
Analgesia and Pain Management
568
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
568
Opioid Receptors: Overview
704
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
704
Opioid Analgesics: Synthetic and Semisynthetic Opioids
271
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
271
Opioid Analgesics: Morphine and Other Natural Cogeners
225
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
225
Drug-Receptor Interaction: Agonist
2.4K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.4K
Nociception
27.8K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
27.8K


